Will the Australia–United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?-Reference-Cited by-同舟云学术

Will the Australia–United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?

Published:2004-09 Issue:5 Volume:181 Page:256-259
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Harvey Ken J¹,Faunce Thomas A²,Lokuge Buddhima²,Drahos Peter²

Affiliation:

1. La Trobe University, Bundoora, VIC.

2. Australian National University, Acton, ACT.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2004.tb06264.x

Reference18 articles.

1. Pharmaceutical Research and Manufacturers of America. National Trade Estimate Report on Foreign Trade Barriers (NTE) 2004. PHRMA 2003. Available at:www.phrma.org/international/resources/2003‐12‐17.466.pdf(accessed Jul 2004).

2. Bush wants end to medicine subsidies;Colebatch T;The Age (Melbourne),2003

3. Productivity Commission. International pharmaceutical price differences: research report. Melbourne July 2001. Available at:www.pc.gov.au/study/pbsprices/finalreport/pbsprices.pdf(accessed Jul 2004).

4. Department of Industry Tourism and Resources. Pharmaceutical Industry Investment Program. 2004. Available at:www.industry.gov.au/content/itrinternet/cmscontent.cfm?objectID=FDBCC43B‐898E‐4433‐AFCA84E5DF7D417D(accessed Jul 2004).

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Right to Health in Australia;Australia’s Engagement with Economic and Social Rights;2021

2. Bounded political contestation: the domestic translation of international health and housing rights in Australia;Australian Journal of Political Science;2017-05-09

3. Free Trade Agreements With The United States: 8 Lessons For Prospective Parties From Australia’s Experience;British Journal of American Legal Studies;2016-12-01

4. The Patenting of Biological Materials in the United States: A State of Policy Confusion;Perspectives on Science;2015-02

5. Reframing the Political Economy of New Drugs;The New Drug Reimbursement Game;2014-07-10